Solvay Pharma India

Solvay Pharma India was a prominent pharmaceutical company in India, operating as a subsidiary of the Belgian Solvay Group's pharmaceutical division. The company specialized in niche therapeutic areas including gastroenterology, women's health, and neuroscience, with a portfolio featuring market-leading brands like Duphaston and Udiliv. In 2010, following the global acquisition of Solvay Pharmaceuticals by Abbott Laboratories, Solvay Pharma India was integrated into Abbott's Indian operations. This acquisition significantly strengthened Abbott's presence in the Indian market, particularly in the specialized segments where Solvay held a dominant position.